title: Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam.
authors.forename: Sándor
authors.initials: S
authors.lastname: Drabant
authors.forename: Mária
authors.initials: M
authors.lastname: Tóth
authors.forename: Andrea
authors.initials: A
authors.lastname: Bereczki
authors.forename: Judit
authors.initials: J
authors.lastname: Bajnógel
authors.forename: Judit
authors.initials: J
authors.lastname: Tömlö
authors.forename: Imre
authors.initials: I
authors.lastname: Klebovich
mesh_terms: D000284:Administration, Oral; D000525:Alprazolam / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D014151:Anti-Anxiety Agents / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D019540:Area Under Curve; D001569:Benzodiazepines / Q000008:administration & dosage / Q000494:pharmacology*; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004347:Drug Interactions; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D001569:Benzodiazepines; D003577:Cytochrome P-450 Enzyme System; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; C012582:tofisopam; D000525:Alprazolam